Skip to main content

ORIGINAL RESEARCH article

Front. Chem.
Sec. Medicinal and Pharmaceutical Chemistry
Volume 13 - 2025 | doi: 10.3389/fchem.2025.1541250
This article is part of the Research Topic Beyond Borders: Exploring Diverse Roles of Heterocyclic Compounds in Combatting Infections and Cancer View all 12 articles

Therapeutic Potential of Laurus nobilis Extract by Experimental and Computational Approaches: Phenolic Content and Bioactivities for Antioxidant, Antidiabetic, and Anticholinergic Properties

Provisionally accepted
  • 1 Erzincan Binali Yildirim University, Fatih Mahallesi, Erzincan, Türkiye
  • 2 Bilecik Sevh Edebali University, Bilecik/Turkiye, Türkiye
  • 3 Erzincan Binali Yildirim University, Erzincan, Erzincan, Türkiye
  • 4 Aksaray University, Aksaray, Aksaray, Türkiye
  • 5 Vignan's Foundation for Science, Technology and Research, Guntur, Andhra Pradesh, India
  • 6 Birla Institute of Technology, Mesra, Ranchi, Jharkhand, India
  • 7 Anadolu University, Eskişehir, Eskişehir, Türkiye
  • 8 Majmaah University, Al Majma'ah, Riyadh, Saudi Arabia

The final, formatted version of the article will be published soon.

    This study investigates the therapeutic potential of Laurus nobilis (LN) leaves, emphasizing their phenolic content and bioactivities, including antioxidant, antidiabetic, and anticholinergic properties. Phenolic compounds in LN ethanol extracts were quantified via LC-MS/MS, while antioxidant activity was assessed using ferric thiocyanate, DPPH, ABTS assays, and metal reduction potentials. Anticholinergic and antidiabetic activities were evaluated through inhibition studies on acetylcholinesterase (AChE), butyrylcholinesterase (BChE), and α-glucosidase (α-GLY) enzymes, complemented by in silico analyses to explore binding mechanisms. Vanillic acid and catechin hydrate were the most abundant phenolics, and LN extract exhibited superior lipid peroxidation inhibition (50.53%) compared to Trolox (28.33%) and α-tocopherol (37.79%) after 24 hours. Moderate radical scavenging and metal reduction potentials were observed, with IC50 values of 2.57 µg/L for AChE, 3.78 µg/L for BChE, and 4.65 µg/L for α-GLY, indicating significant therapeutic potential. In silico findings revealed strong binding affinities of phenolics to the target enzymes, corroborating their bioactivity. This study underscores the promising antioxidant, antidiabetic, and anticholinergic properties of Laurus nobilis extracts and their potential for therapeutic applications.

    Keywords: Laurus nobilis L., Phenolic content, antioxidant, antidiabetic, molecular dynamics, molecular docking

    Received: 07 Dec 2024; Accepted: 21 Jan 2025.

    Copyright: © 2025 Altın, Işık, Alp, Dikici, Köksal, Kırboğa, Rudrapal, Rakshit, Beydemir and Khan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Kevser Kübra Kırboğa, Bilecik Sevh Edebali University, Bilecik/Turkiye, Türkiye
    Mithun Rudrapal, Vignan's Foundation for Science, Technology and Research, Guntur, 522213, Andhra Pradesh, India
    Johra Khan, Majmaah University, Al Majma'ah, 15341, Riyadh, Saudi Arabia

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.